ST. LOUIS, April 26, 2011 /PRNewswire/ -- Centene Corporation (NYSE: CNC) today announced its financial results for the quarter ended March 31, 2011.  The discussions below, with the exception of cash flow information, are in the context of continuing operations and all financial ratios exclude premium taxes.

First Quarter Highlights

  • Quarter-end managed care at-risk membership of 1,542,500, an increase of 71,200 members, or 4.8% year over year.
  • Premium and Service Revenues of $1.2 billion, representing 15.4% year over year growth.
  • Health Benefits Ratio of 83.0%, compared to 84.0% in the prior year.  
  • General and Administrative expense ratio of 13.8%, compared to 13.3% in the prior year.
  • Cash flow from operations of $94.0 million, or 4.1 times net earnings.
  • Diluted earnings per share from continuing operations of $0.46 (which does not include earnings of $0.07 per diluted share as a result of the delay in the recognition of our Mississippi contract discussed below), compared to $0.41 in the prior year.


In January 2011, we began operating in Mississippi through the Mississippi Coordinated Access Network (MississippiCan) program, serving 33,100 members at March 31, 2011.  While the plan has been operating since January 1, 2011 and we have received monthly premium payments and paid claims, the contract remains subject to CMS approval.  Accordingly, we did not recognize revenue of $54.5 million and associated medical costs, which delayed the recognition of earnings of approximately $0.07 per diluted share.  General and administrative expenses related to the Mississippi operations were recognized in our consolidated statement of operations. Upon CMS approval, the revenues, medical costs and related earnings from our Mississippi operations will be recognized in our consolidated statement of operations in the period final approval is obtained, retroactive to January 1, 2011.

Other Events

  • In February 2011, we began operating under an agreement with Pima Health Systems in Arizona to administer their long-term care program on a non-risk basis.
  • In February 2011, Superior HealthPlan began operating under an additional STAR+PLUS ABD contract in Texas in the Dallas service area.
  • In March 2011, Standard & Poor's raised its counterparty credit and senior unsecured debt ratings on Centene Corporation to BB from BB-.
  • In April 2011, CeltiCare Health Plan of Massachusetts, Inc. announced the renewal of its contract with the Commonwealth of Massachusetts to serve Commonwealth Care members, effective July 1, 2011.  CeltiCare will continue to be one of the lowest-cost health plan options for low-income, working adults (up to 300% of the federal poverty level) enrolled in the Commonwealth Care program.


Michael F. Neidorff, Centene's Chairman and Chief Executive Officer, stated, "Our continued focus on fundamentals and enhanced systems capabilities drove solid first quarter performance and a favorable start in a year of opportunity."

The following table depicts membership in Centene's managed care organizations, by state, at March 31, 2011 and 2010:







March 31,





2011



2010

Arizona



22,600



21,700

Florida



188,800



105,900

Georgia



303,300



301,000

Indiana



209,400



211,400

Massachusetts



34,100



26,900

Ohio



160,900



156,000

South Carolina



84,900



53,900

Texas



456,700



459,600

Wisconsin



81,800



134,900

Total at-risk membership (1)



1,542,500



1,471,300

Non-risk membership



10,400



62,200

Total



1,552,900



1,533,500







(1)In January 2011, we began operating in Mississippi through the Mississippi Coordinated Access Network (MississippiCan) program, serving 33,100 members at March 31, 2011.  While the plan has been operating since January 1, 2011 and we have received monthly premium payments and paid claims, the contract remains subject to CMS approval.  





The following table depicts membership in Centene's managed care organizations, by member category, at March 31, 2011 and 2010:







March 31,





2011



2010

Medicaid



1,169,700



1,088,300

CHIP & Foster Care



208,900



266,300

ABD & Medicare



123,800



87,100

Hybrid Programs



35,200



26,900

Long-term Care



4,900



2,700

Total at-risk membership



1,542,500



1,471,300

Non-risk membership



10,400



62,200

Total



1,552,900



1,533,500







Statement of Operations: Three Months Ended March 31, 2011

  • For the first quarter of 2011, Premium and Service Revenues increased 15.4% to $1,179.2 million from $1,022.2 million in the first quarter of 2010.  The increase was primarily driven by membership growth resulting from acquisitions in Florida and South Carolina, conversion of membership in Florida from Access to at-risk under Sunshine State Health Plan, as well as premium rate increases.
  • Consolidated HBR of 83.0% for the first quarter of 2011 represents a decrease of 1.0% from the comparable period in 2010.  The year over year improvement in HBR is due to rate increases and lower utilization levels in 2011.  Consolidated HBR decreased 0.3% sequentially from the fourth quarter of 2010.  
  • Consolidated G&A expense as a percent of premium and service revenues was 13.8% in the first quarter of 2011, an increase from 13.3% in the first quarter of 2010.  The 2011 G&A ratio reflects an increase of 0.6% as a result of including general and administrative expenses for Mississippi but not recording the Mississippi premium revenue discussed above.
  • Earnings from continuing operations increased to $39.1 million in 2011 from $29.6 million in 2010, or 32.0% year over year.  Net earnings from continuing operations were $23.7 million, or $0.46 per diluted share in 2011, compared to $20.1 million, or $0.41 per diluted share in the first quarter of 2010.  


Balance Sheet and Cash Flow

At March 31, 2011, the Company had cash and investments of $1,128.0 million, including $1,096.3 million held by its regulated entities and $31.7 million held by its unregulated entities.  Medical claims liabilities totaled $471.7 million, representing 44.4 days in claims payable.  Total debt was $305.4 million and debt to capitalization was 21.4% at March 31, 2011 excluding the $79.6 million non-recourse mortgage note.  Cash flows from operations were $94.0 million, or 4.1 times net earnings.

A reconciliation of the Company's change in days in claims payable from the immediately preceding quarter-end is presented below:



Days in claims payable, December 31, 2010

45.6



  Reduced time of claims processing and payment

(0.6)



  Reduced utilization

(0.3)



  Pharmacy

(0.3)



Days in claims payable, March 31, 2011

44.4











During the first quarter of 2011, we continued to experience increased electronic claims submissions and auto-adjudication of claims which reduced the average time from claims incurred to claims paid by 0.6 days.  Reduced utilization and the related absence of claims payable due to average completion time decreased days in claims payable by 0.3 days.  Days in claims payable was also reduced by 0.3 days as a result of the timing of pharmacy claims payments.  As we continue to experience increasing claims auto-adjudication (5% increase from the fourth quarter 2010 to the first quarter 2011) and EDI submission rates, our targeted range for days in claims payable is under review.

Outlook

The table below depicts the Company's annual guidance from continuing operations for 2011:







Full Year 2011







Low



High 



Premium and Service Revenues (in millions)



$   4,900



$  5,100



Diluted EPS



$    2.03



$  2.13



Consolidated HBR



83.5% 



84.5% 



General & Administrative expense ratio



12.4% 



12.9% 















Diluted Shares Outstanding (in thousands)



52,000





















Conference Call

As previously announced, the Company will host a conference call Tuesday, April 26, 2011, at 8:30 A.M. (Eastern Time) to review the financial results for the first quarter ended March 31, 2011, and to discuss its business outlook.  Michael F. Neidorff and William N. Scheffel will host the conference call.  Investors and other interested parties are invited to listen to the conference call by dialing 1-800-860-2442 in the U.S. and Canada; +1-412-858-4600 from abroad, or via a live, audio webcast on the Company's website at www.centene.com, under the Investors section.  A webcast replay will be available for on-demand listening shortly after the completion of the call for the next twelve months until 11:59 PM (Eastern Time) on Tuesday, April 24, 2012, at the aforementioned URL. In addition, a digital audio playback will be available until 9:00 AM Eastern Time on Wednesday, May 4, 2011, by dialing 1-877-344-7529 the U.S. and Canada, or +1-412-317-0088 from abroad, and entering access code 449378.

About Centene Corporation

Centene Corporation, a Fortune 500 company, is a leading multi-line healthcare enterprise that provides programs and related services to the rising number of under-insured and uninsured individuals. Many receive benefits provided under Medicaid, including the State Children's Health Insurance Program (CHIP), as well as Aged, Blind or Disabled (ABD), Foster Care and long-term care, in addition to other state-sponsored/hybrid programs, and Medicare (Special Needs Plans). Centene's CeltiCare subsidiary offers states unique, "exchange based" and other cost-effective coverage solutions for low-income populations. The Company operates local health plans and offers a range of health insurance solutions. It also contracts with other healthcare and commercial organizations to provide specialty services including behavioral health, life and health management, managed vision, telehealth services, and pharmacy benefits management.

The information provided in this press release contains forward-looking statements that relate to future events and future financial performance of Centene.  Subsequent events and developments may cause the Company's estimates to change.  The Company disclaims any obligation to update this forward-looking financial information in the future.  Readers are cautioned that matters subject to forward-looking statements involve known and unknown risks and uncertainties, including economic, regulatory, competitive and other factors that may cause Centene's or its industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.  Actual results may differ from projections or estimates due to a variety of important factors, including Centene's ability to accurately predict and effectively manage health benefits and other operating expenses, competition, changes in healthcare practices, changes in federal or state laws or regulations, inflation, provider contract changes, new technologies, reduction in provider payments by governmental payors, major epidemics, disasters and numerous other factors affecting the delivery and cost of healthcare.  The expiration, cancellation or suspension of Centene's Medicaid Managed Care contracts by state governments would also negatively affect Centene.  

(Tables Follow)





CENTENE CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(In thousands, except share data)

(Unaudited)





March 31,

2011



December 31,

2010



ASSETS













Current assets:













Cash and cash equivalents of continuing operations



$

492,045

$

433,914



Cash and cash equivalents of discontinued operations





—



252



Total cash and cash equivalents





492,045



434,166



Premium and related receivables, net of allowance for uncollectible accounts of $17 and $17, respectively





132,023



136,243



Short-term investments, at fair value (amortized cost $51,950 and $21,141, respectively)





52,699



21,346



Other current assets





67,062



64,154



Current assets of discontinued operations other than cash





—



912



Total current assets





743,829



656,821



Long-term investments, at fair value (amortized cost $548,013 and $585,862, respectively)





556,806



595,879



Restricted deposits, at fair value (amortized cost $26,502 and $22,755, respectively)





26,482



22,758



Property, software and equipment, net of accumulated depreciation of $148,051 and $138,629, respectively





334,180



326,341



Goodwill





278,105



278,051



Intangible assets, net





27,813



29,109



Other long-term assets





36,470



30,057



Long-term assets of discontinued operations





—



4,866



Total assets



$

2,003,685

$

1,943,882

















Current liabilities:













Medical claims liability



$

471,659

$

456,765



Accounts payable and accrued expenses





214,900



185,218



Unearned revenue





127,451



117,344



Current portion of long-term debt





3,037



2,817



Current liabilities of discontinued operations





—



3,102



Total current liabilities





817,047



765,246



Long-term debt





302,326



327,824



Other long-term liabilities





53,116



53,378



Long-term liabilities of discontinued operations





—



379



Total liabilities





1,172,489



1,146,827

















Commitments and contingencies



























Stockholders' equity:













Common stock, $.001 par value; authorized 100,000,000 shares; 52,533,873 issued and 49,965,357 outstanding at March 31, 2011, and 52,172,037 issued and 49,616,824 outstanding at December 31, 2010





53



52



Additional paid-in capital





396,380



384,206



Accumulated other comprehensive income:













Unrealized gain on investments, net of tax





5,969



6,424



Retained earnings





477,488



453,743



Treasury stock, at cost (2,568,516 and 2,555,213 shares, respectively)





(50,888)



(50,486)



Total Centene stockholders' equity





829,002



793,939



Noncontrolling interest





2,194



3,116



Total stockholders' equity





831,196



797,055



Total liabilities and stockholders' equity



$

2,003,685

$

1,943,882









CENTENE CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except share data)

(Unaudited)



Three Months Ended

March 31,





2011





2010



Revenues:















Premium

$

1,152,777





$

999,315



Service



26,384







22,907



   Premium and service revenues



1,179,161







1,022,222



Premium tax



37,196







46,499



Total revenues



1,216,357







1,068,721



Expenses:















Medical costs



957,074







839,708



Cost of services



20,176







17,152



General and administrative expenses



162,581







135,507



Premium tax



37,429







46,743



Total operating expenses



1,177,260







1,039,110



Earnings from operations



39,097







29,611



Other income (expense):















Investment and other income



3,749







7,057



Interest expense



(5,695)







(3,813)



Earnings from continuing operations, before income tax expense



37,151







32,855



Income tax expense



14,328







12,525



Earnings from continuing operations, net of income tax expense



22,823







20,330



Discontinued operations, net of income tax expense of $0 and $4,440, respectively



—







3,920



Net earnings



22,823







24,250



Noncontrolling interest



(922)







248



Net earnings attributable to Centene Corporation

$

23,745





$

24,002



















Amounts attributable to Centene Corporation common shareholders:















Earnings from continuing operations, net of income tax expense

$

23,745





$

20,082



Discontinued operations, net of income tax expense



—







3,920



Net earnings

$

23,745





$

24,002



















Net earnings per share attributable to Centene Corporation:















Basic:















   Continuing operations

$

0.48





$

0.43



   Discontinued operations



—







0.08



   Earnings per common share

$

0.48





$

0.51



Diluted:















   Continuing operations

$

0.46





$

0.41



   Discontinued operations



—







0.08



   Earnings per common share

$

0.46





$

0.49



















Weighted average number of shares outstanding:















   Basic



49,750,430







47,260,714



   Diluted



51,811,721







48,761,528









CENTENE CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)



Three Months Ended March 31,





2011



2010

















Cash flows from operating activities:













Net earnings

$

22,823



$

24,250



Adjustments to reconcile net earnings to net cash provided by operating activities













   Depreciation and amortization



14,325





12,527



   Stock compensation expense



4,394





3,460



   Gain on sale of investments, net



(118)





(3,547)



   Gain on sale of UHP



—





(8,201)



   Deferred income taxes



(700)





950



Changes in assets and liabilities













   Premium and related receivables



4,216





(4,457)



   Other current assets



(1,636)





(1,375)



   Other assets



151





1,937



   Medical claims liabilities



13,430





(33,129)



   Unearned revenue



10,106





(73,282)



   Accounts payable and accrued expenses



26,268





40,433



   Other operating activities



732





1,934



Net cash provided by (used in) operating activities



93,991





(38,500)



Cash flows from investing activities:













   Capital expenditures



(15,725)





(12,520)



   Capital expenditures of Centene Center LLC



(1,157)





(10,579)



   Purchases of investments



(40,423)





(146,935)



   Proceeds from asset sales



—





13,420



   Sales and maturities of investments



45,327





117,469



   Investments in acquisitions, net of cash acquired



—





(2,019)



Net cash used in investing activities



(11,978)





(41,164)



Cash flows from financing activities:













   Proceeds from exercise of stock options



6,518





519



   Proceeds from borrowings



127,300





22,030



   Proceeds from stock offering



—





104,557



   Payment of long-term debt



(152,577)





(97,136)



   Distributions to noncontrolling interest



—





(3,585)



   Excess tax benefits from stock compensation



1,132





96



   Common stock repurchases



(402)





(480)



   Debt issue costs



(6,105)





—



Net cash (used in) provided by financing activities



(24,134)





26,001



Net increase (decrease) in cash and cash equivalents



57,879





(53,663)



Cash and cash equivalents, beginning of period



434,166





403,752



Cash and cash equivalents, end of period

$

492,045



$

350,089

















Supplemental disclosures of cash flow information:













   Interest paid

$

1,714



$

345



   Income taxes paid

$

9,567



$

8,272

















Supplemental disclosure of non-cash investing and financing activities:













   Contribution from noncontrolling interest

$

—



$

306



   Capital expenditures

$

1,477



$

789









CENTENE CORPORATION



CONTINUING OPERATIONS SUPPLEMENTAL FINANCIAL DATA





Q1



Q4



Q3



Q2



Q1



2011



2010



2010



2010



2010

MEMBERSHIP



















Managed Care:



















Arizona                           

22,600



22,400



22,300



22,100



21,700

Florida                            

188,800



194,900



116,300



113,100



105,900

Georgia                           

303,300



305,800



300,900



295,600



301,000

Indiana                            

209,400



215,800



213,300



212,700



211,400

Massachusetts                     

34,100



36,200



34,400



30,100



26,900

Ohio                              

160,900



160,100



161,800



159,300



156,000

South Carolina                      

84,900



90,300



90,600



92,600



53,900

Texas                             

456,700



433,100



428,100



475,500



459,600

Wisconsin                         

81,800



74,900



106,100



133,600



134,900

Total at-risk membership (a)     

1,542,500



1,533,500



1,473,800



1,534,600



1,471,300

Non-risk membership                 

10,400



4,200



35,900



50,900



62,200

TOTAL                     

1,552,900



1,537,700



1,509,700



1,585,500



1,533,500





















(a) In January 2011, we began operating in Mississippi through the Mississippi Coordinated Access Network (MississippiCan) program, serving 33,100 members at March 31, 2011.  While the plan has been operating since January 1, 2011 and we have received monthly premium payments and paid claims, the contract remains subject to CMS approval.  





















Medicaid                           

1,169,700



1,177,100



1,122,800



1,135,500



1,088,300

CHIP & Foster Care                  

208,900



210,500



219,100



272,400



266,300

ABD & Medicare                     

123,800



104,600



94,500



93,800



87,100

Hybrid Programs                    

35,200



36,200



34,400



30,100



26,900

Long-term Care                     

4,900



5,100



3,000



2,800



2,700

Total at-risk membership        

1,542,500



1,533,500



1,473,800



1,534,600



1,471,300

Non-risk membership                 

10,400



4,200



35,900



50,900



62,200

TOTAL                     

1,552,900



1,537,700



1,509,700



1,585,500



1,533,500





















Specialty Services(b):



















Cenpatico Behavioral Health



















Arizona                           

172,700



174,600



121,300



119,700



119,300

Kansas                           

44,000



39,200



39,800



39,100



39,800

TOTAL                     

216,700



213,800



161,100



158,800



159,100





















(b) Includes external membership only.





































REVENUE PER MEMBER PER MONTH(c)

$

238.31



$

239.66



$

224.62



$

218.40



$

219.90





















CLAIMS(c)



















Period-end inventory                 

527,100



434,900



469,000



480,400



341,400

Average inventory                  

347,900



304,700



307,500



306,900



283,900

Period-end inventory per member       

0.34



0.28



0.32



0.31



0.23

(c) Revenue per member and claims information are presented for the Managed Care at-risk members.











Q1



Q4



Q3



Q2



Q1



2011



2010



2010



2010



2010





















DAYS IN CLAIMS PAYABLE

44.4



45.6



47.1



48.2



47.7

Days in Claims Payable is a calculation of Medical Claims Liabilities at the end of the period divided by average claims expense per calendar day for such period.





















CASH AND INVESTMENTS (in millions)

















   Regulated                           

$

1,096.3



$

1,043.0



$

895.4



$

813.0



$

917.9

   Unregulated                         



31.7





30.9





32.7





39.4





51.3

       TOTAL                           

$

1,128.0



$

1,073.9



$

928.1



$

852.4



$

969.2





















DEBT TO CAPITALIZATION

26.9%



29.3%



24.7%



24.5%



23.7%

DEBT TO CAPITALIZATION EXCLUDING NON-RECOURSE DEBT(d)

21.4%



23.9%













Debt to Capitalization is calculated as follows: total debt divided by (total debt + total equity).  

(d) The non-recourse debt represents our mortgage note payable of $79.6 million at March 31, 2011 and $80.0 million at December 31, 2010.







OPERATING RATIOS:



Three Months Ended March 31,



2011





2010

Health Benefits Ratios:













   Medicaid and CHIP

82.4

%





85.6

%

   ABD and Medicare

85.1







80.3



   Specialty Services

82.7







80.6



   Total

83.0







84.0

















Total General & Administrative Expense Ratio

13.8

%





13.3

%







MEDICAL CLAIMS LIABILITY (In thousands)

The changes in medical claims liability are summarized as follows:









Balance, March 31, 2010

$

444,826



Incurred related to:







Current period



3,697,199



Prior period



(65,439)



Total incurred



3,631,760



Paid related to:







Current period



3,234,366



Prior period



370,561



Total paid



3,604,927



Balance, March 31, 2011

$

471,659









Centene's claims reserving process utilizes a consistent actuarial methodology to estimate Centene's ultimate liability.  Any reduction in the "Incurred related to:  Prior period" amount may be offset as Centene actuarially determines "Incurred related to: Current period."  As such, only in the absence of a consistent reserving methodology would favorable development of prior period claims liability estimates reduce medical costs.  Centene believes it has consistently applied its claims reserving methodology in each of the periods presented.

The amount of the "Incurred related to: Prior period" above includes the effects of reserving under moderately adverse conditions, new markets where we use a conservative approach in setting reserves during the initial periods of operations, increased receipts from other third party payors related to coordination of benefits and lower medical utilization and cost trends for dates of service prior to March 31, 2010.

SOURCE Centene Corporation

Copyright 2011 PR Newswire

Centene (NYSE:CNC)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Centene Charts.
Centene (NYSE:CNC)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Centene Charts.